Intensive immunosuppression with autologous hematopoietic stem cell reconstitution as therapy for rheumatoid arthritis

Journal of Rheumatology

Volumn 28, Issue SUPPL. 64, 2001, Pages 3-4

  Klassen, L W ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; IMMUNOSUPPRESSIVE AGENT;

AUTOIMMUNITY; AUTOTRANSPLANTATION; CONFERENCE PAPER; DISEASE COURSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PATHOPHYSIOLOGY; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT PLANNING; ANIMAL; IMMUNOLOGY; REVIEW;

ANIMALS; ARTHRITIS, RHEUMATOID; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 0034800127     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice
2. Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains
3. Haemopoietic stem cell transplantation for autoimmune diseases
4. Pre-existing autoimmune disease in patients with longterm survival after allogeneic bone marrow transplantation
5. Autoimmune diseases and autoimmunity post-bone marrow transplantation
6. HLA-DRB1 typing in rheumatoid arthritis: Predicting response to specific treatments